These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10854439)

  • 21. Residue 19 of the parathyroid hormone (PTH) modulates ligand interaction with the juxtamembrane region of the PTH-1 receptor.
    Shimizu M; Shimizu N; Tsang JC; Petroni BD; Khatri A; Potts JT; Gardella TJ
    Biochemistry; 2002 Nov; 41(44):13224-33. PubMed ID: 12403624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A spectroscopic study of the membrane interaction of tuberoinfundibular peptide of 39 residues (TIP39).
    Mason AJ; Lopez JJ; Beyermann M; Glaubitz C
    Biochim Biophys Acta; 2005 Aug; 1714(1):1-10. PubMed ID: 16023614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
    Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
    Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of the vertebrate pth2 (tip39) gene family and the regulation of PTH type 2 receptor (pth2r) and its endogenous ligand pth2 by hedgehog signaling in zebrafish development.
    Bhattacharya P; Yan YL; Postlethwait J; Rubin DA
    J Endocrinol; 2011 Nov; 211(2):187-200. PubMed ID: 21880859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide.
    Bergwitz C; Jusseaume SA; Luck MD; Jüppner H; Gardella TJ
    J Biol Chem; 1997 Nov; 272(46):28861-8. PubMed ID: 9360953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of rat and human parathyroid hormone 2 (PTH2) receptor activation: PTH is a low potency partial agonist at the rat PTH2 receptor.
    Hoare SR; Bonner TI; Usdin TB
    Endocrinology; 1999 Oct; 140(10):4419-25. PubMed ID: 10499494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor.
    Greenberg Z; Bisello A; Mierke DF; Rosenblatt M; Chorev M
    Biochemistry; 2000 Jul; 39(28):8142-52. PubMed ID: 10889020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTH-receptors regulate norepinephrine release in human heart and kidney.
    Potthoff SA; Janus A; Hoch H; Frahnert M; Tossios P; Reber D; Giessing M; Klein HM; Schwertfeger E; Quack I; Rump LC; Vonend O
    Regul Pept; 2011 Nov; 171(1-3):35-42. PubMed ID: 21756942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.
    Bisello A; Manen D; Pierroz DD; Usdin TB; Rizzoli R; Ferrari SL
    Mol Endocrinol; 2004 Jun; 18(6):1486-98. PubMed ID: 14988434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues.
    John MR; Arai M; Rubin DA; Jonsson KB; Jüppner H
    Endocrinology; 2002 Mar; 143(3):1047-57. PubMed ID: 11861531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberoinfundibular peptide of 39 residues (TIP39): molecular structure and activity for parathyroid hormone 2 receptor.
    Della Penna K; Kinose F; Sun H; Koblan KS; Wang H
    Neuropharmacology; 2003 Jan; 44(1):141-53. PubMed ID: 12559132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postnatal development and gender-dependent expression of TIP39 in the rat brain.
    Dobolyi A; Wang J; Irwin S; Usdin TB
    J Comp Neurol; 2006 Sep; 498(3):375-89. PubMed ID: 16871538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of the receptor-ligand complex for parathyroid hormone.
    Rölz C; Pellegrini M; Mierke DF
    Biochemistry; 1999 May; 38(20):6397-405. PubMed ID: 10350457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception.
    Dobolyi A; Ueda H; Uchida H; Palkovits M; Usdin TB
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1651-6. PubMed ID: 11818570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking.
    Behar V; Bisello A; Rosenblatt M; Chorev M
    Endocrinology; 1999 Sep; 140(9):4251-61. PubMed ID: 10465299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid hormone and parathyroid hormone-related protein: model systems for the development of an osteoporosis therapy.
    Mierke DF; Pellegrini M
    Curr Pharm Des; 1999 Jan; 5(1):21-36. PubMed ID: 10066882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart.
    Ross G; Engel P; Abdallah Y; Kummer W; Schluter KD
    Endocrinology; 2005 May; 146(5):2221-8. PubMed ID: 15677763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor. Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation.
    Hoare SR; Gardella TJ; Usdin TB
    J Biol Chem; 2001 Mar; 276(11):7741-53. PubMed ID: 11108715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34).
    Jüppner H; Schipani E; Bringhurst FR; McClure I; Keutmann HT; Potts JT; Kronenberg HM; Abou-Samra AB; Segre GV; Gardella TJ
    Endocrinology; 1994 Feb; 134(2):879-84. PubMed ID: 8299582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor.
    Mann R; Wigglesworth MJ; Donnelly D
    Mol Pharmacol; 2008 Sep; 74(3):605-13. PubMed ID: 18539702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.